V
LIVE

Serial Number

97815175

Owner

Veracyte, Inc.

Attorney

ROSALEEN H. CHOU

Filing Date

Feb 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

V Trademark

Serial Number: 97815175 • Registration: 7637705

V is a trademark filed by Veracyte, Inc. on February 28, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Veracyte, Inc. (31 trademarks)

7000 Shoreline Court
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

February 28, 2023

Registration Date

January 7, 2025

Published for Opposition

November 19, 2024

Goods & Services

Kits for in vitro diagnostic testing for cancers and other diseases; Reagents for medical use; Molecular diagnostic assays for testing of bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Diagnostic medical preparations for use in the field of bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Diagnostic agents, preparations and substances for medical purposes; Diagnostic test kits consisting primarily of reagents for use in testing bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Medical diagnostic test kits consisting primarily of reagents for detecting pathogens; Clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing genetic material; Chemicals, assays, reagents and kits consisting primarily of chemicals, assays, and reagents for medical testing and diagnostic purposes in the fields of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic reagents, and kits comprised of medical diagnostic reagents, collection tubes, buffers, tube holders, transport bags, and instruction sheets, for diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic testing kits comprised primarily of reagents and assays for use in diagnostics and diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use

Reagents for scientific or research use; Diagnostic kits and test kits primarily composed of reagents for determination of genomic and transcriptomic information for scientific or research purposes; Testing kits comprised primarily of preparations, reagents, test strips, collection tubes, buffers, tube holders, transport bags and assays for scientific or research use in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical and veterinary use; Kits comprised primarily of biological reagents and comprised secondarily of a protocol in the form of printed instructions for use thereof for scientific and research purposes; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for scientific or research purposes; Reagents and molecule or cell markers for scientific or research purposes

Medical services; Medical diagnostic testing services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes; Medical diagnostic testing services in the fields of oncology, cancer, and diseases; Genetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Nucleic acid sequencing and analysis services for medical diagnostic and treatment purposes; Genomic and transcriptomic sequencing and analysis services for medical diagnostic and treatment purposes; Genetic analysis and reporting services for medical diagnostic and treatment purposes

Clinical medical research; clinical research in the field of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research trials and studies, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Scientific laboratory research; Scientific laboratory services; Scientific laboratory testing services for disease, cancer, genetics, and pathogens; Scientific laboratory testing and testing, analysis, monitoring, and results reporting services for use in research and development for oncology, cancers, and diseases; Scientific and medical research and development services; Research and development services for others in the field of diagnostic tests, chemicals, compounds and devices; Research and development of new diagnostic tests, clinical products, diagnostic agents and assays; Nucleic acid sequencing, screening, and analysis services for medical research purposes; Genomic and transcriptomic sequencing, screening, and analysis services for medical research purposes; Genetic analysis and reporting services for medical research purposes; Providing medical research services for others featuring research in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Chemical screening analysis and diagnostic services for others for scientific research purposes; Scientific and technological research in the field of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases and diagnostic services for scientific research purposes; Advisory, consultative and telephone help desk services relating to the use of assays and reagents for use in biochemical analysis and diagnostic services; Information and advisory services in the fields of medical research, clinical research, medical laboratory research, and scientific research in the fields of laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Providing online non-downloadable computer software for medical diagnostics and research in the field of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Providing online non-downloadable software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; Providing online non-downloadable software for use in data analysis in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 30, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 7, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 2, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 2, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 3, 2024 GNFN
FINAL REFUSAL E-MAILED
Jul 3, 2024 GNFR
FINAL REFUSAL WRITTEN
Jul 3, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 22, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 22, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 30, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 21, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2023 NWOS
NEW APPLICATION ENTERED
Mar 3, 2023 NWAP